FTC sues major pharmacy profit administrators in excess of insulin selling prices The agency introduced action towards Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record cost of everyday living-preserving insulin medications. Elevance lowers direction on ‘unprecedented’ Medicaid problems Executives m... https://lorenzovndtl.activoblog.com/31758858/not-known-factual-statements-about-healthcare-news